A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)
Public ClinicalTrials.gov record NCT00443391. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Long-Term Safety and Tolerability of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD): An Open-Label Extension Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the long-term safety and tolerability of ABT-089 in adults with ADHD.
Study identification
- NCT ID
- NCT00443391
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 141 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2007
- Primary completion
- Sep 30, 2008
- Completion
- Sep 30, 2008
- Last update posted
- Jan 17, 2013
2007 – 2008
United States locations
- U.S. sites
- 21
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 6109 | Mesa | Arizona | 85210 | — |
| Site Reference ID/Investigator# 6765 | Mesa | Arizona | 85210 | — |
| Site Reference ID/Investigator# 6100 | Lafayette | California | 94549 | — |
| Site Reference ID/Investigator# 6107 | San Diego | California | 92103-8620 | — |
| Site Reference ID/Investigator# 6112 | Jacksonville | Florida | 32216 | — |
| Site Reference ID/Investigator# 6096 | Maitland | Florida | 32751 | — |
| Site Reference ID/Investigator# 6105 | Tampa | Florida | 33606 | — |
| Site Reference ID/Investigator# 6094 | Smyrna | Georgia | 30080 | — |
| Site Reference ID/Investigator# 6111 | Newton | Kansas | 67114 | — |
| Site Reference ID/Investigator# 6113 | Farmington Hills | Michigan | 48336 | — |
| Site Reference ID/Investigator# 6110 | Omaha | Nebraska | 68198 | — |
| Site Reference ID/Investigator# 6099 | New York | New York | 10010 | — |
| Site Reference ID/Investigator# 6106 | Chapel Hill | North Carolina | 27514 | — |
| Site Reference ID/Investigator# 6102 | Portland | Oregon | 97210 | — |
| Site Reference ID/Investigator# 6097 | Charleston | South Carolina | 29405 | — |
| Site Reference ID/Investigator# 6098 | Memphis | Tennessee | 38119 | — |
| Site Reference ID/Investigator# 6103 | Austin | Texas | 78704 | — |
| Site Reference ID/Investigator# 6104 | Lake Jackson | Texas | 77566 | — |
| Site Reference ID/Investigator# 6095 | Herndon | Virginia | 20170 | — |
| Site Reference ID/Investigator# 6092 | Seattle | Washington | 98104 | — |
| Site Reference ID/Investigator# 6101 | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00443391, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2013 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00443391 live on ClinicalTrials.gov.